U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07523789) titled 'Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC' on April 05.
Brief Summary: This study is an observational study that retrospectively collects data of triple-negative breast cancer patients who received neoadjuvant therapy. It compares the bpCR rate, apCR rate, and tpCR rate of patients treated with chemotherapy or immunotherapy, in order to analyze the efficacy and influencing factors of chemotherapy and immunotherapy in neoadjuvant therapy for triple-negative breast cancer.
Study Start Date: May 01
Study Type: OBSERVATIONAL
Condition:
TNBC, Triple Negative Breast Cancer
Recruitment Status: NOT_Y...